Healthcare
Agilent Technologies, Inc.(A)
Live Price
Offline$129.84
+0.22% today
1Y Change
+13.01%
Window
Jun 20, 2025 โ Jun 15, 2026
- Market Cap
- $31.70B
- Revenue Growth
- +6.7%
- EPS Growth
- +3.4%
- Dividend Yield
- 0.7%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Agilent Technologies, Inc. (A) is a Healthcare stock with a market cap of $31.70B and listed on NYSE. The stock last traded around $129.84 and up 13.0% across the available one-year price window (Jun 20, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +6.7%, EPS growth of +3.4%, a dividend yield of 0.7%. What stands out right now is revenue +6.7%, EPS +3.4%, free cash flow -16.1% with operating margin 20.6% and ROIC 12.1%. The dividend is present but secondary, with a yield around 0.7%. Valuation sits in the middle of the pack at P/E 24.6 and price/sales 4.5. Stock Foundry combines A price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.7% vs +7.1% peer median
Operating Margin
Above sector median
+20.6% vs +10.1% peer median
P/E
Below sector median
24.6 vs 101.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 27, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +6.7% and EPS at +3.4%, with operating margin around 20.6%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.7%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +4.0% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 27, 2026 | โ | +16.9% | +18.6% | โ |
2026 Feb 25, 2026 | -0.7% | -3.0% | -3.4% | -9.4% |
2025 Nov 24, 2025 | +0.4% | +2.3% | -3.1% | -9.9% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
A
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
A Max Drawdown
-29.87%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for A and SPY.
Company Overview
Agilent Technologies, Inc.
New York Stock Exchange
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
- Leadership
- Padraig McDonnell
- IPO Date
- Nov 18, 1999
- Employees
- 17.9k
- Street Address
- 5301 Stevens Creek Boulevard
- Mailing
- Santa Clara, CA, 95051
- Region
- Santa Clara, CA, US
- Reporting Currency
- USD
- Investor Line
- 800 227 9770
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 24.6
- EV/EBITDA
- 18.3
- Price/Sales
- 4.5
- Price/Book
- 4.6
Growth
- Revenue
- +6.7%
- EPS
- +3.4%
- Free Cash Flow
- -16.1%
Profitability
- Gross Margin
- 52.2%
- Operating Margin
- 20.6%
- Net Margin
- 18.3%
- ROE
- 19.7%
- ROIC
- 12.1%
Balance Sheet
- Debt/Equity
- 0.49
- Current Ratio
- 2.07
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.